Accendra Health Inc (ACH)vsCencora Inc. (COR)
ACH
Accendra Health Inc
$2.70
+1.89%
HEALTHCARE · Cap: $255.02M
COR
Cencora Inc.
$275.04
-1.90%
HEALTHCARE · Cap: $54.76B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 12002% more annual revenue ($328.68B vs $2.72B). COR leads profitability with a 0.8% profit margin vs -39.8%. COR appears more attractively valued with a PEG of 0.60. COR earns a higher WallStSmart Score of 64/100 (C+).
ACH
Hold44
out of 100
Grade: D
COR
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+71.5%
Fair Value
$8.34
Current Price
$2.70
$5.64 discount
Margin of Safety
-56.3%
Fair Value
$180.05
Current Price
$275.04
$94.99 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Growing faster than its price suggests
Every $100 of equity generates 75 in profit
Earnings expanding 128.3% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 1.2B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -198.4% — below average capital efficiency
Trading at 15.8x book value
3.8% revenue growth
0.8% margin — thin
Operating margin of 1.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : ACH
The strongest argument for ACH centers on Debt/Equity, PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.
Bull Case : COR
The strongest argument for COR centers on Return on Equity, EPS Growth, Altman Z-Score. PEG of 0.60 suggests the stock is reasonably priced for its growth.
Bear Case : ACH
The primary concerns for ACH are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : COR
The primary concerns for COR are Price/Book, Revenue Growth, Profit Margin. Debt-to-equity of 3.65 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
ACH profiles as a turnaround stock while COR is a value play — different risk/reward profiles.
ACH carries more volatility with a beta of 1.63 — expect wider price swings.
COR is growing revenue faster at 3.8% — sustainability is the question.
COR generates stronger free cash flow (1.2B), providing more financial flexibility.
Bottom Line
COR scores higher overall (64/100 vs 44/100). ACH offers better value entry with a 71.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accendra Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?